| ![](/images/empty_line.GIF) |
| |
| |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:000012715 | phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | | | ![](/images/empty_line.GIF) | | |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:O00443 | phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (human) | | | ![](/images/empty_line.GIF) | | |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:O00443-2 | phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha isoform h2 (human) | | | ![](/images/empty_line.GIF) | | |
| |
| |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:O00443 | phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (human) | | | ![](/images/empty_line.GIF) | | |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:O00443-2 | phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha isoform h2 (human) | | | ![](/images/empty_line.GIF) | | |